CLDN16 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis: Konrad and colleagues have suggested a genotype‐phenotype correlation related to the progression of renal failure in FHHNC patients with CLDN16 mutations (Konrad et al., 2008).